Julie has more than 25 years of experience in clinical translation of cellular therapies and regenerative medicine products, including business management and board directorship experience. She has eight years of experience as an executive officer with a publicly traded company building services for cellular banking, including licensure of technology with more than 30 affiliates. She is an experienced scientist who excels at delivering innovation, driving milestones, maintaining sensitivity to financial considerations, building multidisciplinary teams, as well as strategic planning, project management, and regulatory expertise. Dr. Allickson has a history of creating value in clinical development and translation.
*****
A person listed as a contributor has spoken or otherwise participated in Federalist Society events, publications, or multimedia presentations. A person's appearance on this list does not imply any other endorsement or relationship between the person and the Federalist Society. In most cases, the biographical information on a person's "contributor" page is provided directly by the person, and the Federalist Society does not edit or otherwise endorse that information. The Federalist Society takes no position on particular legal or public policy issues. All expressions of opinion by a contributor are those of the contributor.
It Can Be Done Live: The Future of Our Health
A Four-Part Virtual Movie Premiere
The creators of the award-winning documentary, They Say It Can't Be Done, in partnership with the...
It Can Be Done Live: The Future of Our Health
A Four-Part Virtual Movie Premiere
The creators of the award-winning documentary, They Say It Can't Be Done, in partnership with the...
Deep Dive Episode 136 – It Can Be Done Live: The Future of Our Health
Regulatory Transparency Project's Fourth Branch Podcast
The creators of the award-winning documentary, They Say It Can’t Be Done, in partnership with...